International Journal of Gastroenterology

Archive

Volume 8, Issue 1, June 2024

  • Research Article

    Outcome of Infants Discharged Home from the Neonatal Unit with Partial Nasogastric Feeds

    Shivani Kamal, Indira Chandrasekar

    Issue: Volume 8, Issue 1, June 2024
    Pages: 1-4
    Received: 12 January 2024
    Accepted: 24 January 2024
    Published: 5 February 2024
    Downloads:
    Views:
    Abstract: Aim: In our previous publication, we proposed an algorithm for safely discharging infants from the neonatal intensive care unit (NICU) on partial nasogastric feeds (NGF), thus avoiding gastrostomy tube placement (GTP) for infants who were unable to take full oral feeds. This follow up study post intervention, is to determine the number of patients ... Show More
  • Research Article

    Onset of Irritable Bowel Syndrome, Dyspepsia, Diarrhea, Bloating, and Constipation in Deployed Gulf War Veterans

    Zachary Thomas Verne, Jeremy Zachary Fields, George Nicholas Verne, Benjamin Buyi Zhang, Amber Leigh Thacker, QiQi Zhou*

    Issue: Volume 8, Issue 1, June 2024
    Pages: 5-10
    Received: 15 January 2024
    Accepted: 29 January 2024
    Published: 5 February 2024
    Downloads:
    Views:
    Abstract: An estimated 694,550 United States service members were actively deployed to the Persian Gulf from 1990-1991. Many veterans who were deployed developed Persian Gulf War Syndrome along with chronic gastrointestinal symptoms after returning from the Persian Gulf. Our objective in this study was to determine the phenotypic expression of gastrointestin... Show More
  • Case Report

    A Case of Pemrolizumab-Associated Severe Gastritis Treated with Mycophenolate Mofetil

    Emin Bodakçi*

    Issue: Volume 8, Issue 1, June 2024
    Pages: 11-13
    Received: 12 March 2024
    Accepted: 29 March 2024
    Published: 11 April 2024
    Downloads:
    Views:
    Abstract: Immune checkpoint inhibitors have become a frequently used treatment in oncology practice. Although it has approved indications in many types of cancer, phase studies are ongoing in many types of cancer. Side effects due to the increasing use of immune checkpoint inhibitors have begun to be seen frequently. Cases of colitis, pancreatitis and hepati... Show More
  • Review Article

    The Role of Lactobacillus Reuteri Probiotic for Preventing Functional Gastrointestinal Disorders in Toddlerhood

    Mohammad Basir Uddin*, Shahab Uddin, Bishwajit Deb, Tania Hussain, Sohel Al Rafi, Azizul Islam

    Issue: Volume 8, Issue 1, June 2024
    Pages: 14-21
    Received: 28 February 2024
    Accepted: 18 March 2024
    Published: 11 April 2024
    Downloads:
    Views:
    Abstract: Probiotic Lactobacillus reuteri has been shown to be useful for a number of gastrointestinal disorders. Its ability to secrete antimicrobial compounds, prevent pathogenic microorganisms from colonizing the host, and alter the composition of the commensal microbiota in the host are all major contributors to its therapeutic advantages. Not only that,... Show More
  • Research Article

    D-dimer Level Is Non-Specifically Elevated Post-Living-Related Liver Transplantation in Children

    Hadil Samir Darwish*, Nermin Mohamed Adawy, Magdy Anwar Saber, Noha Mohamed Radwan

    Issue: Volume 8, Issue 1, June 2024
    Pages: 22-31
    Received: 18 April 2024
    Accepted: 3 May 2024
    Published: 17 May 2024
    Downloads:
    Views:
    Abstract: Background/Objective: D-dimer, a soluble fibrin degradation product, is used to be a marker of vascular thrombosis. However, it has been reported to be elevated in different pathological conditions other than thrombosis. Moreover, its pattern post-liver transplantation (LT) in children is not known. So, we aimed to report its pattern within the fir... Show More
  • Case Report

    Rare Clinically Significant Idiosyncratic Drug Induced Liver Injury Caused by Low Dose Atorvastatin: Time for a New Approach to Surveillance and Risk Identification

    Adebola Adetiloye*, Olurotimi Badero

    Issue: Volume 8, Issue 1, June 2024
    Pages: 32-41
    Received: 28 February 2024
    Accepted: 5 June 2024
    Published: 6 June 2024
    DOI: 10.11648/j.ijg.20240801.16
    Downloads:
    Views:
    Abstract: Background: Atorvastatin is a member of the class of cholesterol lowering drugs called statins, which works by inhibiting HMG-CoA reductase, an enzyme involved in cholesterol synthesis in the liver. Statins are used to reduce the risk of cardiovascular events in individuals who have risk factors or a history of cardiovascular disease. While atorvas... Show More